Navigation Links
Ariosa Diagnostics Selected as NIPT Service Provider in Majority of California Comprehensive Prenatal Diagnosis Centers Throughout the State
Date:11/1/2013

SAN JOSE, Calif., Nov. 1, 2013 /PRNewswire/ -- Ariosa Diagnostics, Inc., maker of the Harmony™ Prenatal Test, announced today that it has been selected as a key provider of non-invasive prenatal testing (NIPT) services in the majority of the 28 comprehensive Prenatal Diagnosis Centers (PDC) throughout the State of California. The Harmony test, which is the most widely used NIPT globally, is being offered to pregnant women as part of the California Prenatal Screening Program at no additional cost, subject to the program requirements.

(Logo: http://photos.prnewswire.com/prnh/20130225/SF62999LOGO)

Currently, the California Prenatal Screening Program offers traditional serum and neural tube defect screening to the general population of pregnant women. Patients found to be screen positive for possible chromosome conditions (such as Down syndrome or trisomy 18), or have an increased nuchal translucency measurement, are referred for other services that include genetic counseling, ultrasound, amniocentesis and chorionic villus sampling (CVS). Given its increased sensitivity and specificity, the State has now introduced NIPT as another option in evaluating patients who have an increased risk for chromosome conditions based on their serum screening results. 

The Harmony test has the most published data of any NIPT available for pregnant women of any age, fetal gestational age and risk-profile. Published in over 13 peer-reviewed studies, involving thousands of patients, the test has demonstrated greater than 99% accuracy for Down syndrome with a less than 0.1% false positive rate, thereby diminishing the potential for women to unnecessarily proceed to invasive diagnostic procedures that may result in pregnancy complications in an otherwise normal fetus.  

About Ariosa Diagnostics

Ariosa Diagnostics, Inc. is a molecular diagnostics company committed to innovating together to improve patient care. The flagship product, the HarmonyTM Prenatal Test, is a safe, highly accurate and affordable prenatal test for maternal and fetal health. Led by an experienced team, Ariosa is using its proprietary technology to perform a directed analysis of cell-free DNA in blood. The HarmonyTM Prenatal Test equips pregnant women and their healthcare providers with reliable information to make decisions regarding their health, without creating unnecessary stress or anxiety.

The company began operations in 2010 and is headquartered in San Jose, Calif. For more information, visit www.ariosadx.com. Follow us on Twitter @HarmonyPrenatal and on Facebook at Harmony Prenatal for Healthy Pregnancy.

CONTACT:
Jen Bruursema
408-229-7539
jbruursema@ariosadx.com


'/>"/>
SOURCE Ariosa Diagnostics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Ariosa Diagnostics Wins Summary Judgment Against Sequenom on Cell-free DNA Patent
2. Ariosa Diagnostics Introduces Y-Chromosome Analysis Test Option
3. Ariosa Diagnostics to Present and Exhibit at the 16th International Conference on Prenatal Diagnosis and Therapy
4. PDI, Inc. Appoints Molecular Diagnostics Leader to Board of Directors
5. Does Your Business Have the Tools to Compete in the Worlds Largest Diagnostics Markets?
6. Exagen Diagnostics Appoints New Board Member
7. Frost & Sullivan Unveils Future Opportunities for the Tissue Diagnostics Market
8. DNA Diagnostics Center (DDC), One of the Worlds Largest DNA Testing Companies, Increases the Identification Power of its DNA Tests by More Than 500%
9. Ampio Pharmaceuticals subsidiary Luoxis Diagnostics announces positive summary data from study of traumatic brain injury patients and issuance of companys third US patent for its oxidation-reduction potential diagnostic platform
10. Life Technologies and Advanced Cell Diagnostics Sign Global Distribution Agreement
11. Increasing Public Health Awareness Intensifies Global Uptake of Autoimmune Disease Diagnostics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... Research and Markets has announced the addition of ... report to their offering. ... kidney failure, it replaces the function of kidneys by removing ... thus the treatment helps to keep the patient body,s electrolytes ... Increasing number of ESRD patients & substantial healthcare expenditure ...
(Date:6/23/2016)... 2016 Research and Markets has ... by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), ... Parenteral) - Global Forecast to 2021" report to ... The global pharmaceutical excipients market is projected to reach ... 6.1% in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... 23, 2016 Roche (SIX: RO, ROG; OTCQX: ... its Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated ... shock. With this clearance, Roche is the first IVD ... solution for sepsis risk assessment and management. ... and PCT levels in blood can aid clinicians in ...
Breaking Medicine Technology:
(Date:6/26/2016)... Charlotte, NC (PRWEB) , ... June 26, 2016 , ... Brent Kasmer, a legally blind ... able to be personalized through a fitness app. The fitness app plans to fix the ... solutions currently only offer a one size fits all type program , They ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the ... several important health care topics including advance care planning, healthcare costs and patient ...
(Date:6/25/2016)... ... ... closing of Bruton Memorial Library on June 21 due to a possible lice infestation, as ... of head lice: the parasite’s ability to live away from a human host, and to ... one in the event that lice have simply gotten out of control. , As lice ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room ... Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. ... of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson ... Recently, he has implemented orthobiologic procedures as a method for treating his patients. ... the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons ...
Breaking Medicine News(10 mins):